Treatment of hypertension complicated with hyperuricemia
10.12092/j.issn.1009-2501.2022.04.012
- Author:
Yuanfang LI
1
;
Zhaoqiang CUI
1
Author Information
1. Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases
- Publication Type:Journal Article
- Keywords:
Angiotonin receptor blocker;
Hypertension;
Hyperuricemia;
Thiazide diuretics;
Xanthine oxidase inhibitor
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2022;27(4):428-432
- CountryChina
- Language:Chinese
-
Abstract:
Hypertension and hyperuricemia often coexist, and have a high incidence and often incur great harm. The current guidelines recommend active control of uric acid and blood pressure levels. But patients with high uric acid and high blood pressure still need detailed guidelines to standardize the treatment to avoid incurring more drug-related side effects. This article reviews the epidemiology and clinical harm, the therapeutic target value, the consensus and controversy on therapeutic treatment of high blood pressure combined with high uric acid.
